HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tom Kennedy Selected Research

mebeverine

4/2010Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care.
4/2008Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome.
8/2005Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tom Kennedy Research Topics

Disease

3Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
04/2010 - 08/2005
1Encephalomyelitis (Myeloencephalitis)
05/2020
1Cicatrix (Scar)
06/2014
1Chronic Renal Insufficiency
06/2014
1Encephalitis (Encephalitis, Rasmussen)
01/2006

Drug/Important Bio-Agent (IBA)

3mebeverineIBA
04/2010 - 08/2005
2ponazurilIBA
05/2020 - 01/2006
2Parasympatholytics (Antispasmodics)IBA
04/2010 - 08/2005
1Allopurinol (Remid)FDA LinkGeneric
06/2014

Therapy/Procedure

1Therapeutics
08/2005